Our Mission. How does Colorado Medicaid Work? Objectives

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "Our Mission. How does Colorado Medicaid Work? Objectives"

Transcription

1 How does Colorado Medicaid Work? Understanding the Delivery of Pharmaceutical Care Cathy Traugott, JD, RPh Client and Clinical Care Office Pharmacy Unit Manager Department of Health Care Policy and Financing Our Mission Improving health care access and outcomes for the people we serve while demonstrating sound stewardship of financial resources Objectives 1. Recognize the process supporting development of the preferred drug list and prior authorization criteria and the prior authorization process 2. Understand recent or anticipated changes to drug classes covered by Medicaid 3. Understand departmental initiatives to improve quality and safety of care for patients related to pain management, prescription drug abuse, and opioid overuse 4. Identify opportunities to optimize drug therapy management through Medicaid Medication Therapy Management (MTM) and the Regional Care Collaborative Organizations (RCCOs) 1

2 CE Questions 1. What does the process for drug coverage on the PDL entail? A. Clinical review by P&T Committee and Department B. Stakeholder input C. Prior authorization criteria development with DUR Board input D. All of the above 2. What were the key findings in the DUR reports regarding opioids? A. 90.3% of prescriptions were for short-acting opioids B. Over 2,000 members were receiving in excess of 100 mg/day morphine dose equivalents C. 14.6% of members receiving opioids were less than 18 years of age D. All of the above 3. True or False: The Department pays for MTM-like services. CE Questions (continued) 4. True or False: The goal of the ACC is increased coordinated care. 5. What are the criteria for pharmacist participation in RX Review? A. There are no criteria. B. It just requires a Colorado pharmacist license. C. The pharmacist must have an unrestricted pharmacist license in Colorado, liability insurance, and meet certain educational requirements. Drug Coverage Policies Medicaid programs must cover all rebateable drugs for medically accepted indications Allowable restrictions Preferred Drug List Prior Authorizations Quantity Limits/ Age Restrictions provider-forms 2

3 Preferred Drug List (PDL) Department determines drug classes subject to PDL Drug classes are reviewed annually New drugs in an existing drug class on the PDL are generally added as a non-preferred drug PDL is published on the Department s website Preferred Drug List (PDL) The Pharmacy and Therapeutics (P&T) Committee Reviews a drug class for safety and efficacy 7 physicians, 4 pharmacists, 2 client representatives - independent of Department Prior to and during P&T meetings the Committee hears public testimony from stakeholders Committee submits recommendations to the Department Department determines preferred status of drugs Non-Preferred drugs are referred to Drug Utilization Review (DUR) Board for recommendations on prior authorization criteria Preferred Drug List (PDL) The Drug Utilization Review (DUR) Board Recommends criteria based on clinical information, public testimony and drug utilization review analysis 4 physicians, 4 pharmacists, 1 non-voting pharmaceutical industry representative - independent of Department Board makes recommendations to Department on clinical appropriateness and cost effectiveness Department evaluates recommendations in order to develop prior authorization criteria for PDL 3

4 Prior Authorizations Appendix P Drugs subject to prior authorization that are not included on the PDL are listed on Appendix P The DUR Board often makes recommendations on prior authorization criteria for these drugs as well Department makes final determination for prior authorization criteria Ex: Synagis, Short-Acting Opioids, Smoking Cessation Products Prior Authorization Process What happens after a claim is rejected at the pharmacy? Physician or an agent of the physician may call the PA Help Desk for a prior authorization ( ) or fax PA request form to some pharmacies may call as well Prescribers must sign all PA request forms PA escalation may be requested to be reviewed by a department clinical pharmacist System generated letter sent to member and prescriber as an approval or a denial Appeal of a denial may be sent to Office of Administrative Courts Recent and Anticipated Changes in Drug Classes 1. Growth Hormones 2. Opioids 3. Hepatitis C Virus 4. Cystic Fibrosis 5. Tobacco Cessation 4

5 Example - Hepatitis C Timeline of review of new drugs Criteria developed with input from DUR Board and community stakeholders PA Forms: %2003%2001%20Viekira%20Prior%20Authorization %20Form.pdf %2003%2001%20Sovaldi%20Harvoni%20Prior %20Authorization%20Form.pdf Pain Management Initiatives 1. Governor s Initiative 2. New short-acting opioid policy 3. Pain Management Resources on Department web page 4. Upcoming morphine equivalent policy 5. Chronic Pain Disease Management Program (Project ECHO) Governor s Initiative 1. Started as an initiative with National Governor s Association Governor Hickenlooper, co-chair of Policy Academy to Reduce Prescription Drug Abuse 2. Resulted in Colorado Plan to Reduce Prescription Drug Abuse - a coordinated, statewide strategy; simultaneously restricts access to Rx drugs for illicit use, while ensuring access for those who legitimately need them. 3. Colorado Consortium for Prescription Drug Abuse Prevention 4. Initiatives to improve quality and safety of care for patients related to pain management, prescription drug abuse, and opioid overuse 5

6 Medicaid Opioid History Quantity limits were placed on long-acting opioids Long-acting opioids were added to the Preferred Drug List No prior authorization criteria on short-acting opioids Drug Utilization Review Analysis The Department s DUR contractor, the University of Colorado s School of Pharmacy, completed 2 reports analyzing opioid use in Medicaid population First report analyzed prescribing and usage of shortacting and long-acting opioids DUR evaluation conducted at 3 levels of analysis: the prescription level, the patient level, and the provider level. Second report provided method to identify high utilizers and potential policy recommendations to the Department Drug Utilization Review Findings 90.3% of prescriptions were for short-acting opioids Over 2,000 members were receiving in excess of 100 mg/day morphine dose equivalents 14.6% of members receiving opioids were less than 18 years of age For those members receiving in excess of 100 mg/day morphine dose equivalents, 33.3%, 17.7%, 7.9%, and 4.2% were receiving 2, 3, 4 or 5+ opioids The majority of prescribers appear to be physicians 8.1% are family/pediatric nurse practitioners, 11.6% are physician assistants, 7.8% are dentists and 1% are podiatrists 6

7 Drug Utilization Review Findings (continued) DUR contractor evaluated risk of opioid overdose in highutilizers of opioid medications Analysis was limited to morphine equivalents, number of pharmacies used, and days supply to help identify possible criteria for the Department Based on these 3 variables, risk of overdose from opioids is over 10-fold for people who have morphine equivalent doses greater than 100mg, who use more than three pharmacies, and have more than 300 days supply of opiates. Short-Acting Opioid Policy On August 1, 2014, the Department implemented limits on short-acting opioids of a maximum of 4 tablets per day (equating to 120 tablets per 30 days) Exceptions can be made for terminal illnesses and sickle cell anemia Prescribers can request a 6-month override for members receiving more than 120 tablets per 30 days in order to have time to taper down to 4 tablets per day Other states have similar policies Short-Acting Opioid Policy On August 25, 2014, clarifications were made for acute pain Exceptions can be made for more than 4 tablets per day for acute pain This can be handled by the pharmacy and does not require prescriber intervention The total number of pills still cannot exceed 120 in 30 days 7

8 Pain Management Resources Provider Resources (billing and referrals) Pain Assessment Risk Assessment (abuse or misuse) Reporting/ Monitoring Opioid Use (PDMP) Tapering, Converting, Discontinuing Pain Guidelines Patient Education Non-pharmaceutical options Next Steps The Department will monitor impact of this policy Review the impact on short-acting and long-acting utilization Further review of members receiving the highest doses of opioids Further review of the prior authorization criteria for both shortacting and long-acting opioids The Department is working toward review of claims by morphine equivalents rather than per pill Chronic Pain Disease Management Program Modeled after the Project ECHO (Extension for Community Healthcare Outcomes) programs Two year initiative Cutting edge telehealth technologies connect PCMPs to specialists 8

9 Purpose Improve health of Medicaid clients with chronic pain and painrelated opioid dependence Address rising rates of prescription abuse Foster collaboration between PCPs and specialty care providers Promote adherence to evidence-based guidelines Support practice change to improve management of chronic pain Components 1. Chronic Pain Provider Collaborative 2. Buprenorphine Provider Collaborative 3. Practice Transformation Learning Collaborative Provider Collaboratives Modelled after Project ECHO Sessions led by multidisciplinary team of specialists Virtual clinics using easy-to-access videoconferencing tools Short didactic presentations Cases presented by participating PCPs for consultation Specialists provide recommendations and best practices that can be implemented within PCP office 9

10 Provider Collaboratives 1. Chronic Pain Provider Collaborative Designed for CO Medicaid providers Reinforce CO policies (e.g. Quad Policy) 2. Buprenorphine Provider Collaborative Designed for licensed providers Feature specialists in addiction and substance use disorders Provider Collaboratives Year-long with Bi-monthly sessions minute didactic 90-minutes of case presentations Website Benefits: Available to all practice providers, not just attendees. Recordings from all ECHO sessions, searchable by topic Chat function allows sharing of resources, knowledge and professional services during session Provider Collaboratives Multidisciplinary teams of specialists to include: Behavioral health specialist Pharmacist Pain management specialist 10

11 Practice Transformation Learning Collaborative Assist practices with: Identifying systems-level gaps Developing action plans Adherence to evidence-based guidelines Drug Therapy Management The Department recognizes benefits of MTM MTM needs to be coordinated with other Department initiatives to be effective This includes the Accountable Care Collaborative (ACC) and the corresponding Regional Care Collaborative Organizations (RCCOs) ACC Approach Not traditional managed care Offers full benefits of Medicaid Connects members to medical and non-medical (social) services to support health Coordinated care at regional level 11

12 Strategies Every member has a Primary Care Medical Provider (PCMP) All ACC members and PCMPs belong to a local Regional Care Collaborative Organization (RCCO) Unprecedented access to data from the Statewide Data and Analytics Contractor (SDAC) Gradual introduction of payment strategies to reward outcomes instead of volume The Accountable Care Collaborative Regional Care Collaborative Organizations (RCCOs) Primary Care Medical Providers (PCMPs) Statewide Data and Analytics Contractor (SDAC) RCCO Map Region 1 Region 2 Region 3 Region 4 Region 5 Region 6 Region 7 Rocky Mountain Health Plans Colorado Access Colorado Access Integrated Community Health Partners Colorado Access Colorado Community Health Alliance Community Care of Central Colorado 12

13 RCCO Role Achieve financial and health outcomes Ensure a Medical Home level of care for every Member Network Development/Management Provider Support Medical Management and Care Coordination Accountability/Reporting PCMP serves as a Medical Home Member/family centered Whole person oriented Coordinated Promotes client selfmanagement Care provided in a culturally sensitive and linguistically sensitive manner Accessible PCMP Role SDAC Role Data Repository Data Analytics & Reporting Web Portal & Access Accountability & Continuous Improvement 39 13

14 Patient Data Available to PCMPs Value of the ACC Net savings of about $30 million Clients > 6 months in the ACC ER visits decreased for adults (21%) and children (2%) High cost imaging services were significantly lower for adults (35%) and children (19%) 30-day, all cause hospital readmissions were 33% lower for both adults and children Value of the ACC ACC clients, since 2012: Children with disabilities: 6% h in the number of professional care visits 7% i in ER visits Children with asthma 16% i in the number of preventable services Adults with disabilities 29% i in 30-day, all cause hospital readmissions Adults with diabetes 7% h in the number of professional visits 14

15 Prescription Drug Consumer Information & Technical Assistance Program Rx Review MTM light not formally approved as an MTM program Created through state legislation HB , C.R.S Client participation in program is voluntary Program is designed for high utilizers Receiving 5 or more medications per month For 3 months Totaling $2,000 or more in expenditures in each month Rx Review - How it Works Dept contracts with pharmacists who want to participate Contracted Pharmacists must meet qualifications set forth by the Colorado Board of Pharmacy. Contracted pharmacists complete medication reviews in person/by phone for targeted clients including: Screening for drug-drug and drug-otc/supplement interactions Screening for duplicative drug therapy Evaluating client's response to current therapy, including drug effectiveness and safety Correcting patterns of clients using multiple prescribers and/or pharmacies Department receives pharmacist s recommendation letter Payment: $75 face-to-face; $50 phone consultation 44 Rx Review - The Goals Achieve drug therapy treatment goals; Minimize undesirable medication effects; Improve client medication adherence; Enhance medication safety; and Reduce health expenditures

16 Drug Therapy Management and RCCOs Rx Review and RCCOs - independent programs Department encouraged and facilitated meetings between the RCCOs and pharmacy stakeholders for coordinated MTM and ACC efforts MTM services must be coordinated with other care coordination efforts in order to be effective Encourage continued discussions as the RCCOs evolve CE Questions 1. What does the process for drug coverage on the PDL entail? A. Clinical review by P&T Committee and Department B. Stakeholder input C. Prior authorization criteria development with DUR Board input D. All of the above 2. What were the key findings in the DUR reports regarding opioids? A. 90.3% of prescriptions were for short-acting opioids B. Over 2,000 members were receiving in excess of 100 mg/day morphine dose equivalents C. 14.6% of members receiving opioids were less than 18 years of age D. All of the above 3. True or False: The Department pays for MTM-like services. CE Questions (continued) 4. True or False: The goal of the ACC is increased coordinated care. 5. What are the criteria for pharmacist participation in RX Review? A. There are no criteria. B. It just requires a Colorado pharmacist license. C. The pharmacist must have an unrestricted pharmacist license in Colorado, liability insurance, and meet certain educational requirements. 16

17 Thank You Cathy Traugott, JD, RPh Client and Clinical Care Office Pharmacy Unit Manager Department of Health Care Policy & Financing 17

Accountable Care Collaborative Colorado Department of Health Care Policy and Financing

Accountable Care Collaborative Colorado Department of Health Care Policy and Financing Accountable Care Collaborative Colorado Department of Health Care Policy and Financing 1 Healthcare Reform Accountable Care Organizations (ACOs) National Health Reform Accountable Care Collaborative (ACC)

More information

Colorado s Accountable Care Collaborative

Colorado s Accountable Care Collaborative Colorado s Accountable Care Collaborative Suzanne Brennan, Medicaid Director May 19, 2013 Who We Serve 2 Alignment with Triple Aim 3 HCPF Goals 1. Transforming our systems from a medical model to a health

More information

ACC Program History. Colorado s Accountable Care Collaborative Phase II. Community Behavioral Health Services Program History.

ACC Program History. Colorado s Accountable Care Collaborative Phase II. Community Behavioral Health Services Program History. Colorado s Accountable Care Collaborative Phase II An Overview ACC Program History Created in response to: Unsuccessful experience with capitated Managed Care 85% in an unmanaged Fee-For-Service (FFS)

More information

Colorado Prescription Drug Monitoring Program. Department of Regulatory Agencies Division of Professions and Occupations State Board of Pharmacy

Colorado Prescription Drug Monitoring Program. Department of Regulatory Agencies Division of Professions and Occupations State Board of Pharmacy Colorado Prescription Drug Monitoring Program Department of Regulatory Agencies Division of Professions and Occupations State Board of Pharmacy DORA is dedicated to preserving the integrity of the marketplace

More information

Substance Use: Addressing Addiction and Emerging Issues

Substance Use: Addressing Addiction and Emerging Issues MODULE 6: SUBSTANCE USE: ADDRESSING ADDICTION AND EMERGING ISSUES Substance Use: Addressing Addiction and Emerging Issues Martha C. Romney, RN, MS, JD, MPH Assistant Professor Jefferson School of Population

More information

2015 REPORT Steven W. Schierholt, Esq. Executive Director www.pharmacy.ohio.gov

2015 REPORT Steven W. Schierholt, Esq. Executive Director www.pharmacy.ohio.gov OHIO AUTOMATED RX REPORTING SYSTEM 2015 REPORT Steven W. Schierholt, Esq. Executive Director www.pharmacy.ohio.gov OHIO AUTOMATED RX REPORTING SYSTEM What is OARRS? To address the growing misuse and diversion

More information

COLORADO DEPARTMENT OF HEALTH CARE POLICY AND FINANCING

COLORADO DEPARTMENT OF HEALTH CARE POLICY AND FINANCING COLORADO DEPARTMENT OF HEALTH CARE POLICY AND FINANCING LEGISLATIVE REQUEST FOR INFORMATION # 4 COMPREHENSIVE MEDICATION MANAGEMENT NOVEMBER 1, 2013 Legislative Request for Information #4 states: The Department

More information

Fraud, Waste and Abuse

Fraud, Waste and Abuse Fraud, Waste and Abuse CT - Fraud Hotline submitted by Connecticut The Fraud Hotline at the Department of Social Services (DSS) is a proactive approach to handling complaints regarding fraud and abuse

More information

Opioid Prescribing for Chronic Pain: Guidelines for Marin County Clinicians

Opioid Prescribing for Chronic Pain: Guidelines for Marin County Clinicians Opioid Prescribing for Chronic Pain: Guidelines for Marin County Clinicians Although prescription pain medications are intended to improve the lives of people with pain, their increased use and misuse

More information

For a Healthier America: Reducing Prescription Drug Misuse and Abuse

For a Healthier America: Reducing Prescription Drug Misuse and Abuse For a Healthier America: Reducing Prescription Drug Misuse and Abuse The misuse and abuse of prescription medicines is a growing public health problem. In addition to the tragic toll on families and communities,

More information

Pharmacy and the Medicaid Accountable Care Organization

Pharmacy and the Medicaid Accountable Care Organization RCCO Pilot Project CDC Grant Increase engagement of non-physician team members (ie., pharmacists) in Hypertension (HTN) and Diabetes Mellitus (DM) management in health care systems; Increase the proportion

More information

MEDICAL ASSISTANCE BULLETIN

MEDICAL ASSISTANCE BULLETIN ISSUE DATE SUBJECT EFFECTIVE DATE MEDICAL ASSISTANCE BULLETIN NUMBER *See below BY Prior Authorization of Opiate Dependence Treatments Pharmacy Service Leesa M. Allen, Deputy Secretary Office of Medical

More information

The Colorado Medicaid Accountable Care Collaborative Program

The Colorado Medicaid Accountable Care Collaborative Program The Colorado Medicaid Accountable Care Collaborative Program September 12, 2011 Colorado Center on Law and Policy 789 Sherman St., Suite 300, Denver, CO 80203 303-573-5669 Colorado Medicaid s Accountable

More information

18% Role of Pharmacist-Provided Medication Reviews in Workers Compensation Claims Management. Introduction. Role of the Pharmacist

18% Role of Pharmacist-Provided Medication Reviews in Workers Compensation Claims Management. Introduction. Role of the Pharmacist Role of Pharmacist-Provided Medication Reviews in Workers Compensation Claims Management Benjamin Link, PharmD, RPh Introduction According to information from the National Council on Compensation Insurance

More information

Colorado s Accountable Care Collaborative

Colorado s Accountable Care Collaborative Colorado s Accountable Care Collaborative Creating a Culture of Change Presented by: Susan Mathieu February 10, 2015 1 Presentation Outline ACC Overview Initiatives Support for Behavioral Health Integration

More information

Care Coordination and Community Case Management Partner Meeting

Care Coordination and Community Case Management Partner Meeting Care Coordination and Community Case Management Partner Meeting To ensure the right care, in the right order, at the right time, in the right setting 1 Today s Objectives What is Integrated Community Health

More information

Accountable Care and Value Based Payments 101: Government Programs Update

Accountable Care and Value Based Payments 101: Government Programs Update 1 Accountable Care and Value Based Payments 101: Government Programs Update June 24 th, 2014 Dave Neiman, FSA, MAAA Senior Consulting Actuary DaveN@Wakely.com (720) 226-9806 2 Caveats Opinions expressed

More information

EXPLORING NALOXONE UPTAKE AND USE PUBLIC MEETING July 01 02, 2015 Fred Wells Brason II fbrason@projectlazarus.org

EXPLORING NALOXONE UPTAKE AND USE PUBLIC MEETING July 01 02, 2015 Fred Wells Brason II fbrason@projectlazarus.org EXPLORING NALOXONE UPTAKE AND USE PUBLIC MEETING July 01 02, 2015 Fred Wells Brason II fbrason@projectlazarus.org Disclosures Project Lazarus Zogenix Charitable Contribution 2015 Kaléo Charitable Contribution

More information

STATE PLAN TO PREVENT AND TREAT PRESCRIPTION DRUG ABUSE RECOMMENDATION SUMMARY Governor s Prescription Drug Abuse Prevention Council

STATE PLAN TO PREVENT AND TREAT PRESCRIPTION DRUG ABUSE RECOMMENDATION SUMMARY Governor s Prescription Drug Abuse Prevention Council STATE PLAN TO PREVENT AND TREAT PRESCRIPTION DRUG ABUSE RECOMMENDATION SUMMARY Governor s Prescription Drug Abuse Prevention Council PRIORITY AREA: PRESCRIBERS Recommendation: The Council recommends that

More information

MEDICAL ASSISTANCE BULLETIN

MEDICAL ASSISTANCE BULLETIN ISSUE DATE September 4, 2015 SUBJECT EFFECTIVE DATE September 9, 2015 MEDICAL ASSISTANCE BULLETIN NUMBER *See below BY Prior Authorization of Opiate Dependence Treatments, Oral Buprenorphine Agents - Pharmacy

More information

Request for Information: Opioid Analgesic Prescriber Education and Training Opportunities to Prevent Opioid Overdose and Opioid Use Disorder

Request for Information: Opioid Analgesic Prescriber Education and Training Opportunities to Prevent Opioid Overdose and Opioid Use Disorder This document is scheduled to be published in the Federal Register on 07/08/2016 and available online at http://federalregister.gov/a/2016-16067, and on FDsys.gov DEPARTMENT OF HEALTH AND HUMAN SERVICES

More information

The Federation of State Medical Boards 2013 Model Guidelines for Opioid Addiction Treatment in the Medical Office

The Federation of State Medical Boards 2013 Model Guidelines for Opioid Addiction Treatment in the Medical Office The Federation of State Medical Boards 2013 Model Guidelines for Opioid Addiction Treatment in the Medical Office Adopted April 2013 for Consideration by State Medical Boards 2002 FSMB Model Guidelines

More information

WAC Pain management Intent. These rules govern the use of opioids in the treatment of patients for chronic noncancer pain.

WAC Pain management Intent. These rules govern the use of opioids in the treatment of patients for chronic noncancer pain. WAC 246-853-660 Pain management Intent. These rules govern the use of opioids in the treatment of patients for chronic noncancer pain. WAC 246-853-661 Exclusions. The rules adopted under this section do

More information

Opioids and the Injured Worker Tools for Successful Outcomes

Opioids and the Injured Worker Tools for Successful Outcomes Opioids and the Injured Worker Tools for Successful Outcomes Tim Pokorney, RPh Director, Clinical Express Scripts Workers' Compensation Division Goals and Objectives Alarming statistics for narcotic utilization,

More information

Guidelines for the Use of Controlled Substances in the Treatment of Pain Adopted by the New Hampshire Medical Society, July 1998

Guidelines for the Use of Controlled Substances in the Treatment of Pain Adopted by the New Hampshire Medical Society, July 1998 Guidelines for the Use of Controlled Substances in the Treatment of Pain Adopted by the New Hampshire Medical Society, July 1998 Section I: Preamble The New Hampshire Medical Society believes that principles

More information

FEHB Program Carrier Letter All FEHB Carriers

FEHB Program Carrier Letter All FEHB Carriers FEHB Program Carrier Letter All FEHB Carriers U.S. Office of Personnel Management Healthcare and Insurance Letter No. 2016-03 Date: February 26, 2016 Fee-for-service [3] Experience-rated HMO [3] Community-rated

More information

02 DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION

02 DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION Effective June 13, 2010 02-313, 02-373, 02-380, 02-383, 02-396 Chapter 21 page 1 02 DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION 313 BOARD OF DENTAL EXAMINERS 373 BOARD OF LICENSURE IN MEDICINE

More information

Concept Series Paper on Disease Management

Concept Series Paper on Disease Management Concept Series Paper on Disease Management Disease management is the concept of reducing health care costs and improving quality of life for individuals with chronic conditions by preventing or minimizing

More information

Arkansas Emergency Department Opioid Prescribing Guidelines

Arkansas Emergency Department Opioid Prescribing Guidelines Arkansas Emergency Department Opioid Prescribing Guidelines 1. One medical provider should provide all opioids to treat a patient s chronic pain. 2. The administration of intravenous and intramuscular

More information

Expanding access to treatment for opiate addiction: Successes and Barriers

Expanding access to treatment for opiate addiction: Successes and Barriers Expanding access to treatment for opiate addiction: Successes and Barriers Miriam Komaromy, MD Medical Director, Turquoise Lodge Addiction Treatment Hospital, NM Department of Health; and UNM Project ECHO

More information

DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services. NEW products from the Medicare Learning Network (MLN)

DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services. NEW products from the Medicare Learning Network (MLN) Medicare Advantage Outreach and Education Bulletin Anthem Blue Cross Prescription Drug Monitoring Programs Prescription drug abuse and diversion are acute problems in the area of pain management. The Centers

More information

The Cost of Pain and Economic Burden of Prescription Misuse, Abuse and Diversion. Angela Huskey, PharmD, CPE

The Cost of Pain and Economic Burden of Prescription Misuse, Abuse and Diversion. Angela Huskey, PharmD, CPE The Cost of Pain and Economic Burden of Prescription Misuse, Abuse and Diversion Angela Huskey, PharmD, CPE Case Bill is a 47 year old man with a history of low back pain and spinal stenosis Not a real

More information

Colorado Consortium for Prescription Drug Abuse Prevention:

Colorado Consortium for Prescription Drug Abuse Prevention: Colorado Consortium for Prescription Drug Abuse Prevention: Quarterly Update to the SATF Robert Valuck, PhD, RPh Coordinating Center Director Helen Kaupang Associate Director Friday, February 7, 2014 #2

More information

Colorado Access Regional Care Collaborative Organization Reference Guide Accountable Care Collaborative

Colorado Access Regional Care Collaborative Organization Reference Guide Accountable Care Collaborative 2011 Colorado Access Regional Care Collaborative Organization Reference Guide Accountable Care Collaborative Colorado Access 10/19/2011l Contents Content Page Number Accountable Care Collaborative 3 ACC

More information

5557 FAQs & Definitions

5557 FAQs & Definitions 5557 FAQs & Definitions These Questions and Answers are intended to present information that has been acquired as part of the discovery process and provides necessary context for the Policy Directives

More information

Palmer MacKie, MD MS Director, Integrative Pain Program, Eskenazi Department of Medicine, IUSOM

Palmer MacKie, MD MS Director, Integrative Pain Program, Eskenazi Department of Medicine, IUSOM Palmer MacKie, MD MS Director, Integrative Pain Program, Eskenazi Department of Medicine, IUSOM Attorney General s Prescription Drug Abuse Task Force Member AIT Laboratories Advisory Board In 2009, 44%

More information

1) What would it take to get four or five FQHCs to implement ECHO, and how many patients can we serve?

1) What would it take to get four or five FQHCs to implement ECHO, and how many patients can we serve? RI Mental Health Summit Lightning Round Q&A s June 8, 2015 Opiate Addiction Epidemic 1) What would it take to get four or five FQHCs to implement ECHO, and how many patients can we serve? 2) What would

More information

CHAPTER 535 HEALTH HOMES. Background... 2. Policy... 2. 535.1 Member Eligibility and Enrollment... 2. 535.2 Health Home Required Functions...

CHAPTER 535 HEALTH HOMES. Background... 2. Policy... 2. 535.1 Member Eligibility and Enrollment... 2. 535.2 Health Home Required Functions... TABLE OF CONTENTS SECTION PAGE NUMBER Background... 2 Policy... 2 535.1 Member Eligibility and Enrollment... 2 535.2 Health Home Required Functions... 3 535.3 Health Home Coordination Role... 4 535.4 Health

More information

Managed Care Reforms. Ohio Healthcare Policy and Political Update. Physician Ranking Programs SB 121 - Physician Ranking Programs

Managed Care Reforms. Ohio Healthcare Policy and Political Update. Physician Ranking Programs SB 121 - Physician Ranking Programs Ohio Healthcare Policy and Political Update Jeffrey S. Smith, JD, Director, Government Relations Managed Care Reforms Administrative Simplification SB 136 Health Insurance Modernization Act Prohibit unilateral

More information

Utah Clinical Guidelines on Prescribing Opioids

Utah Clinical Guidelines on Prescribing Opioids Utah Clinical Guidelines on Prescribing Opioids Presented by: Erin Johnson, MPH January 2009 www.useonlyasdirected.org Overview Utah s prescription problem Why guidelines? Guideline process Guideline content

More information

Policy for the issue of permits to prescribe Schedule 8 poisons

Policy for the issue of permits to prescribe Schedule 8 poisons Policy for the issue of permits to prescribe Schedule 8 poisons May 2011 Introduction The Victorian Drugs, Poisons and Controlled Substances (DPCS) legislation sets out certain circumstances when a medical

More information

TREATMENT MODALITIES. May, 2013

TREATMENT MODALITIES. May, 2013 TREATMENT MODALITIES May, 2013 Treatment Modalities New York State Office of Alcoholism and Substance Abuse Services (NYS OASAS) regulates the addiction treatment modalities offered in New York State.

More information

Policy for Prescribing and Dispensing Opioids

Policy for Prescribing and Dispensing Opioids Policy for Prescribing and Dispensing Opioids Colorado Dental Board, Colorado Medical Board, State Board of Nursing, and State Board of Pharmacy In collaboration with the Nurse-Physician Advisory Task

More information

Pain Management Regulations Affect More Than Pain Management Specialists January 2012. Of counsel to

Pain Management Regulations Affect More Than Pain Management Specialists January 2012. Of counsel to Pain Management Regulations Affect More Than Pain Management Specialists January 2012 LINDA A. KEEN MSN, JD, LHCRM LAW OFFICE OF LINDA A. KEEN P.A. TALLAHASSEE, FL Of counsel to Pain Management Regulations

More information

Appendix to Tennessee Department of Health: Tennessee Clinical Practice Guidelines for Outpatient Management of Chronic Non- Malignant Pain

Appendix to Tennessee Department of Health: Tennessee Clinical Practice Guidelines for Outpatient Management of Chronic Non- Malignant Pain Appendix to Tennessee Department of Health: Tennessee Clinical Practice Guidelines for Outpatient Management of Chronic Non- Malignant Pain Division of Workers Compensation 04.01.2015 Background Opioids

More information

Massachusetts Substance Abuse Policy and Practices. Senator Jennifer L. Flanagan Massachusetts Worcester and Middlesex District

Massachusetts Substance Abuse Policy and Practices. Senator Jennifer L. Flanagan Massachusetts Worcester and Middlesex District Massachusetts Substance Abuse Policy and Practices Senator Jennifer L. Flanagan Massachusetts Worcester and Middlesex District November 2014 Substance Abuse and Addiction National and State opioid abuse

More information

Managed Care Pharmacy. Objectives. Health Plans Some Background 4/7/2015. Kim Moon, PharmD Spring 2015

Managed Care Pharmacy. Objectives. Health Plans Some Background 4/7/2015. Kim Moon, PharmD Spring 2015 Managed Care Pharmacy Kim Moon, PharmD Spring 2015 Objectives Describe the role of pharmacists in managed care plans Discuss the role of quality ratings systems in managed care pharmacy Explain some of

More information

JOB ANNOUNCEMENT. 40 hours per week. $80,100 - $90,000 per year DOQ (1 FTE) Grade 14 Exempt status

JOB ANNOUNCEMENT. 40 hours per week. $80,100 - $90,000 per year DOQ (1 FTE) Grade 14 Exempt status JOB ANNOUNCEMENT POSITION TITLE: POSITION NUMBER: 80-001 HOURS: Time limited Full-Time 40 hours per week Position is funded for two years, with possible extension. This position requires some flexibility

More information

Prior Authorization of buprenophine/naloxone (Suboxone ) or buprenorphine (Subutex )

Prior Authorization of buprenophine/naloxone (Suboxone ) or buprenorphine (Subutex ) June 2010 April 2009 Prior Authorization of buprenophine/naloxone (Suboxone ) or buprenorphine (Subutex ) Effective August 1, West Virginia Medicaid will require prior authorization for all Suboxone and

More information

APPENDIX B: VENDOR DRUG PROGRAM TEXAS MEDICAID PROVIDER PROCEDURES MANUAL: VOL. 1

APPENDIX B: VENDOR DRUG PROGRAM TEXAS MEDICAID PROVIDER PROCEDURES MANUAL: VOL. 1 APPENDIX B: VENDOR DRUG PROGRAM TEXAS MEDICAID PROVIDER PROCEDURES MANUAL: VOL. 1 AUGUST 2015 TEXAS MEDICAID PROVIDER PROCEDURES MANUAL: VOL. 1 AUGUST 2015 APPENDIX B: VENDOR DRUG PROGRAM Table of Contents

More information

Governor s Task Force on Mental Health and Substance Use. www.ncdhhs.gov/mhsu

Governor s Task Force on Mental Health and Substance Use. www.ncdhhs.gov/mhsu Governor s Task Force on Mental Health and Substance Use www.ncdhhs.gov/mhsu Problem Statement 97 Painkiller prescriptions per 100 North Carolinians Number of deaths by drug overdose in North Carolina

More information

MEETING OF THE DRUG SAFETY AND RISK MANAGEMENT ADVISORY COMMITTEE MEETING: RISKS AND BENEFITS OF HYDROCODONE COMBINATION ANALGESIC PRODUCTS

MEETING OF THE DRUG SAFETY AND RISK MANAGEMENT ADVISORY COMMITTEE MEETING: RISKS AND BENEFITS OF HYDROCODONE COMBINATION ANALGESIC PRODUCTS MEETING OF THE DRUG SAFETY AND RISK MANAGEMENT ADVISORY COMMITTEE MEETING: RISKS AND BENEFITS OF HYDROCODONE COMBINATION ANALGESIC PRODUCTS David Gaugh, R.Ph. Senior Vice President for Sciences and Regulatory

More information

Considerations when Using Controlled Substances to Treat Chronic Pain

Considerations when Using Controlled Substances to Treat Chronic Pain Considerations when Using Controlled Substances to Treat Chronic Pain By Mary-Beth F. Plum, Pharm.D. Impact of Chronic Pain Acute pain is the body s response to environmental dangers, and it helps protect

More information

HAWAII BOARD OF MEDICAL EXAMINERS PAIN MANAGEMENT GUIDELINES

HAWAII BOARD OF MEDICAL EXAMINERS PAIN MANAGEMENT GUIDELINES Pursuant to section 453-1.5, Hawaii Revised Statutes, the Board of Medical Examiners ("Board") has established guidelines for physicians with respect to the care and treatment of patients with severe acute

More information

Blue Rx Clinical Pharmacy Programs SM. Formulating the future of pharmacy. Employer Guide

Blue Rx Clinical Pharmacy Programs SM. Formulating the future of pharmacy. Employer Guide Experience. Wellness. Everywhere. SM Blue Rx Clinical Pharmacy Programs SM Formulating the future of pharmacy Employer Guide Contents Introduction...1 Formulary Management...2 Concurrent Drug Utilization

More information

Ernest Boyd, R.Ph., MBA Executive Director Ohio Pharmacists Association

Ernest Boyd, R.Ph., MBA Executive Director Ohio Pharmacists Association Ernest Boyd, R.Ph., MBA Executive Director Ohio Pharmacists Association CDC s Guide for Pharmacist Partnership for Public Health Brief overview of Pharmacists All graduate with 6 to 8 year Doctor of Pharmacy

More information

The Patient-Centered Medical Home How Does Managed Care Pharmacy Add Value?

The Patient-Centered Medical Home How Does Managed Care Pharmacy Add Value? The Patient-Centered Medical Home How Does Managed Care Pharmacy Add Value? With heath care reform now being implemented, it is important that managed care pharmacy understand how to provide value for

More information

Mandatory Prescriber Usage of the Kentucky All Schedule Prescription Electronic Reporting System (KASPER)

Mandatory Prescriber Usage of the Kentucky All Schedule Prescription Electronic Reporting System (KASPER) Mandatory Prescriber Usage of the Kentucky All Schedule Prescription Electronic Reporting System (KASPER) David R. Hopkins KASPER Program Manager Office of Inspector General Kentucky Cabinet for Health

More information

U.S. House of Representatives Committee on Energy and Commerce Subcommittee on Health

U.S. House of Representatives Committee on Energy and Commerce Subcommittee on Health TESTIMONY of the American Medical Association before the U.S. House of Representatives Committee on Energy and Commerce Subcommittee on Health Re: Examining Legislative Proposals to Combat our Nation's

More information

Prioritizing Comparative Effectiveness Research Questions: PCORI Stakeholder Workshops. March 7, 2016

Prioritizing Comparative Effectiveness Research Questions: PCORI Stakeholder Workshops. March 7, 2016 Prioritizing Comparative Effectiveness Research Questions for Management of Sickle Cell Disease: Questions submitted for consideration by workshop participants Prioritizing Comparative Effectiveness Research

More information

Prescribers required to check PDMP before first prescription for Controled Substances for new patient.

Prescribers required to check PDMP before first prescription for Controled Substances for new patient. State, District, or Territory Alabama Arizona Arkansas Colorado Connecticut Delaware Georgia Guam Criteria for Mandatory Enrollment or Query of PDMP Before renewing an Alabama Controlled Substances Certificate,

More information

MEDICAID DRUG SPENDING ON ANTI- ADDICTION MEDICATION AND OPIOID ADDICTION REFRESHER

MEDICAID DRUG SPENDING ON ANTI- ADDICTION MEDICATION AND OPIOID ADDICTION REFRESHER MEDICAID DRUG SPENDING ON ANTI- ADDICTION MEDICATION AND OPIOID ADDICTION REFRESHER TWO PRIMARY ACCESS POINTS Pharmacy Benefit Dispensed by a Pharmacy Billed via the PBM Process (NCPCP) Oversight by Drug

More information

HHS Opioid Research Portfolio Brief Translating Science into Action

HHS Opioid Research Portfolio Brief Translating Science into Action The U.S. is in the midst of an unprecedented opioid overdose epidemic. In 2014, of the 47,055 drug overdose deaths in the U.S., 28,647 (61%) involved a prescription or illicit opioid. The public health

More information

Presentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas

Presentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas Presentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas David Lakey, MD Commissioner, Department of State Health Services Lauren Lacefield Lewis Assistant Commissioner,

More information

Prior Authorization Guideline

Prior Authorization Guideline Prior Authorization Guideline Guideline: CSD - Suboxone Therapeutic Class: Central Nervous System Agents Therapeutic Sub-Class: Analgesics and Antipyretics (Opiate Partial Agonists) Client: County of San

More information

PRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE

PRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE PRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE May 19, 2012 National Association Boards of Pharmacy Annual Meeting Gil Kerlikowske, Director White House Office of National Drug Control Policy ONDCP

More information

PHARMACEUTICAL MANAGEMENT PROCEDURES

PHARMACEUTICAL MANAGEMENT PROCEDURES PHARMACEUTICAL MANAGEMENT PROCEDURES THE FORMULARY The purpose of Coventry Health Care s formulary is to encourage use of the most cost-effective drugs. The formulary is necessary because the cost of prescription

More information

Implementing Prescribing Guidelines in the Emergency Department. April 16, 2013

Implementing Prescribing Guidelines in the Emergency Department. April 16, 2013 Implementing Prescribing Guidelines in the Emergency Department April 16, 2013 Housekeeping Note: Today s presentation is being recorded and will be provided within 48 hours. Two ways to ask questions

More information

Integrating Data to Support Care Management Transformation

Integrating Data to Support Care Management Transformation Integrating Data to Support Care Management Transformation The Washington State Experience David Mancuso, PhD Director, Research and Data Analysis Division Washington State Department of Social and Health

More information

Resource Guide. Antidepressant Medication Management. A helpful resource for primary care physicians

Resource Guide. Antidepressant Medication Management. A helpful resource for primary care physicians Resource Guide Antidepressant Medication Management A helpful resource for primary care physicians August 2015 Depression Management Managing your patients with depression This booklet provides an overview

More information

The Heroin and Opioid Epidemic in Northeast Ohio: One Year Report to the Community

The Heroin and Opioid Epidemic in Northeast Ohio: One Year Report to the Community The Heroin and Opioid Epidemic in Northeast Ohio: One Year Report to the Community The Heroin and Opioid Epidemic in Northeast Ohio: One Year Report to the Community November 2014 INTRODUCTION The Heroin

More information

Maryland Cancer Plan Pain Management Committee

Maryland Cancer Plan Pain Management Committee Maryland Cancer Plan Pain Management Committee IDEAL MODEL FOR CANCER CONTROL PROBLEM or ISSUE Lack of provider awareness regarding appropriate pain assessment and management and relevant policy Definition:

More information

Statement. of the. American Medical Association. to the

Statement. of the. American Medical Association. to the Statement of the American Medical Association to the Committee on Energy & Commerce Subcommittee on Oversight and Investigations United States House of Representatives Re: Combatting the Opioid Abuse Epidemic:

More information

Integrating Behavioral Health and Primary Health Care: Development, Maintenance, and Sustainability Cici Conti Schoenberger, LCSW, CAS Behavioral

Integrating Behavioral Health and Primary Health Care: Development, Maintenance, and Sustainability Cici Conti Schoenberger, LCSW, CAS Behavioral Integrating Behavioral Health and Primary Health Care: Development, Maintenance, and Sustainability Cici Conti Schoenberger, LCSW, CAS Behavioral Health Provider Sunshine Community Health Center Why Integrate?

More information

Maureen Mangotich, MD, MPH Medical Director

Maureen Mangotich, MD, MPH Medical Director Maureen Mangotich, MD, MPH Medical Director Prepared for the National Governors Association Healthy America: State Policy Leaders Meeting, December 2005 Delivering value from the center of healthcare Pharmaceutical

More information

Opiate Addiction in Ohio: An Update on Scope of Problem Ashland Ohio

Opiate Addiction in Ohio: An Update on Scope of Problem Ashland Ohio Governor s Cabinet Opiate Action Team Promoting Wellness and Recovery John R. Kasich, Governor Tracy J. Plouck, Director Opiate Addiction in Ohio: An Update on Scope of Problem Ashland Ohio November 14,

More information

TESTIMONY. March 17, 2014. Rutland, VT

TESTIMONY. March 17, 2014. Rutland, VT Community Solutions to Breaking the Cycle of Heroin & Opioid Addiction TESTIMONY Harry Chen, MD, Commissioner of Health March 17, 2014 Senate Committee on the Judiciary Franklin Conference Center at the

More information

Opioid Treatment Guidelines. Denis G. Patterson, DO University of Nevada, Reno 7/15/2015

Opioid Treatment Guidelines. Denis G. Patterson, DO University of Nevada, Reno 7/15/2015 Opioid Treatment Guidelines Denis G. Patterson, DO University of Nevada, Reno 7/15/2015 Opioid Treatment Guidelines Opioid Treatment Guidelines Chronic opioid therapy to treat chronic non-cancer pain (CNCP)

More information

PharmaCare is BC s public drug insurance program that assists BC residents in paying for eligible prescription drugs and designated medical supplies.

PharmaCare is BC s public drug insurance program that assists BC residents in paying for eligible prescription drugs and designated medical supplies. PHARMANET AND PHARMACARE DATA DICTIONARY Date Range: September 1, 1995 to present date, data is provided by calendar year Data Source: BC Ministry of Health Description The PharmaNet system is an online,

More information

Treatment Approaches for Drug Addiction

Treatment Approaches for Drug Addiction Treatment Approaches for Drug Addiction NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please call 1-800-662-HELP(4357)

More information

Testimony to the Senate Committee on Veterans Affairs and Health S. B. 739. February 27, 2014. What is an Accountable Care Organization or ACO?

Testimony to the Senate Committee on Veterans Affairs and Health S. B. 739. February 27, 2014. What is an Accountable Care Organization or ACO? Testimony to the Senate Committee on Veterans Affairs and Health S. B. 739 Professor Sidney D. Watson Center for Health Law Studies Saint Louis University School of Law February 27, 2014 My name is Sidney

More information

2015 Indiana General Assembly

2015 Indiana General Assembly 2015 Indiana General Assembly As of Tuesday: 454 Senate Bills 349 House Bills Budget Full funding of Medicaid forecast $19M - IU medical school campus in Evansville $8M Enhance awareness and provide prenatal

More information

Title: The Certified Medication Assisted Treatment Advocate (CMA) Training Course

Title: The Certified Medication Assisted Treatment Advocate (CMA) Training Course The American Association for the Treatment of Opioid Dependence, provider #1044, is approved as a provider for social work continuing education by the Association of Social Work Boards (ASWB) www.aswb.org,

More information

CHAPTER 114. AN ACT establishing a Medicaid Accountable Care Organization Demonstration Project and supplementing Title 30 of the Revised Statutes.

CHAPTER 114. AN ACT establishing a Medicaid Accountable Care Organization Demonstration Project and supplementing Title 30 of the Revised Statutes. CHAPTER 114 AN ACT establishing a Medicaid Accountable Care Organization Demonstration Project and supplementing Title 30 of the Revised Statutes. BE IT ENACTED by the Senate and General Assembly of the

More information

FISCAL IMPACT STATEMENT. LS 7351 NOTE PREPARED: Feb 6, 2015 BILL NUMBER: SB 464 BILL AMENDED: Feb 5, 2015

FISCAL IMPACT STATEMENT. LS 7351 NOTE PREPARED: Feb 6, 2015 BILL NUMBER: SB 464 BILL AMENDED: Feb 5, 2015 LEGISLATIVE SERVICES AGENCY OFFICE OF FISCAL AND MANAGEMENT ANALYSIS 200 W. Washington, Suite 301 Indianapolis, IN 46204 (317) 233-0696 http://www.in.gov/legislative FISCAL IMPACT STATEMENT LS 7351 NOTE

More information

MANAGEMENT OF CHRONIC NON MALIGNANT PAIN

MANAGEMENT OF CHRONIC NON MALIGNANT PAIN MANAGEMENT OF CHRONIC NON MALIGNANT PAIN Introduction The Manitoba Prescribing Practices Program (MPPP) recognizes the important role served by physicians in relieving pain and suffering and acknowledges

More information

Mayor s Task Force On Prescription Painkiller Abuse

Mayor s Task Force On Prescription Painkiller Abuse Mayor s Task Force On Prescription Painkiller Abuse Interim Report January 2013 BACKGROUND In response to a growing epidemic, in late 2011 Mayor Bloomberg created the multi-agency Task Force on Prescription

More information

Disease Management Identifications and Stratification Health Risk Assessment Level 1: Level 2: Level 3: Stratification

Disease Management Identifications and Stratification Health Risk Assessment Level 1: Level 2: Level 3: Stratification Disease Management UnitedHealthcare Disease Management (DM) programs are part of our innovative Care Management Program. Our Disease Management (DM) program is guided by the principles of the UnitedHealthcare

More information

Understanding Hepatitis C Treatment Access

Understanding Hepatitis C Treatment Access Understanding Hepatitis C Treatment Access Robert Greenwald, JD, Clinical Professor of Law & Director, Center for Health Law and Policy Innovation of Harvard Law School May 2015 Comments Based on Findings

More information

Collaborative Drug Therapy

Collaborative Drug Therapy Legislation and regulations affecting pharmacists practice guidelines vary according to the legislative styles and practices of each state. The following information highlights the legislative elements

More information

Opioid Therapy and Physician Communication Guidelines

Opioid Therapy and Physician Communication Guidelines Opioid Therapy and Physician Communication Guidelines i Medication Storage Medication Disposal Prescriber Education Patient Information Contents Best Practice Guidelines Recommendations... 1 Acute Care

More information

Florida Medicaid Prescribed Drug Service Spending Control Initiatives. For the Quarter July 1, 2014 through September 30, 2014

Florida Medicaid Prescribed Drug Service Spending Control Initiatives. For the Quarter July 1, 2014 through September 30, 2014 Florida Medicaid Prescribed Drug Service Spending Control Initiatives For the Quarter July 1, through September 30, Report to the Florida Legislature September 2015 Table of Contents Purpose of Report...

More information

Kaiser Permanente of Ohio

Kaiser Permanente of Ohio Kaiser Permanente of Ohio Chronic Disease Management Program March 11, 2011 Presenters: Amy Kramer and Audrey L. Callahan 1 Objectives 1. Define the roles and responsibilities of the Care Managers in the

More information

Future Service Directions

Future Service Directions Alcohol, Tobacco and Other Drug Services Tasmania Future Service Directions A five year plan 2008/09 2012/13 Department of Health and Human Services Contents Foreword... 5 Introduction... 6 Australian

More information

Colorado Plan to Reduce Prescription Drug Abuse

Colorado Plan to Reduce Prescription Drug Abuse Colorado Plan to Reduce Prescription Drug Abuse September 2013 Kelly Perez Policy Advisor Office of Governor John Hickenlooper The Colorado Team (2012/2013) Christine Adams Statistical Analyst/Researcher

More information

MQAC Rules for the Management of Chronic Non-Cancer Pain

MQAC Rules for the Management of Chronic Non-Cancer Pain MQAC Rules for the Management of Chronic Non-Cancer Pain Effective January 2, 2012 246-919-850 Pain management Intent. These rules govern the use of opioids in the treatment of patients for chronic noncancer

More information

Formulary Management

Formulary Management Formulary Management Formulary management is an integrated patient care process which enables physicians, pharmacists and other health care professionals to work together to promote clinically sound, cost-effective

More information

Management of Substance Use in the Pregnancy Medical Home Setting Sara McEwen, MD, MPH Executive Director, Governor s Institute

Management of Substance Use in the Pregnancy Medical Home Setting Sara McEwen, MD, MPH Executive Director, Governor s Institute Management of Substance Use in the Pregnancy Medical Home Setting Sara McEwen, MD, MPH Executive Director, Governor s Institute 1 Webinar Objectives Describe SBIRT approach to manage substance use in pregnancy

More information

Protecting your employees, the physicians and you. Opioid abuse is being talked about every day. Modern Medical has a solution.

Protecting your employees, the physicians and you. Opioid abuse is being talked about every day. Modern Medical has a solution. TM Protecting your employees, the physicians and you. Opioid abuse is being talked about every day. Modern Medical has a solution. Goals of Opioid Defense Manager TM Opioids are the most common drugs prescribed

More information